98 related articles for article (PubMed ID: 8274713)
1. Modification of opioid receptors and uncoupling of receptors from G proteins as possible mechanisms underlying suppression of opioid binding by cholecystokinin octapeptide.
Zhang L; Wang X; Han J
Chin Med Sci J; 1993 Mar; 8(1):1-4. PubMed ID: 8274713
[TBL] [Abstract][Full Text] [Related]
2. Modification by cholecystokinin octapeptide of the binding of mu-, delta-, and kappa-opioid receptors.
Wang XJ; Han JS
J Neurochem; 1990 Oct; 55(4):1379-82. PubMed ID: 2168937
[TBL] [Abstract][Full Text] [Related]
3. Cholecystokinin-8 suppressed 3H-etorphine binding to rat brain opiate receptors.
Wang XJ; Fan SG; Ren MF; Han JS
Life Sci; 1989; 45(2):117-23. PubMed ID: 2545992
[TBL] [Abstract][Full Text] [Related]
4. [Binding of [3H] dihydroetorphine to opioid receptors in rat brain membrane].
Wang DX; Qin BY
Zhongguo Yao Li Xue Bao; 1996 May; 17(3):281-3. PubMed ID: 9812759
[TBL] [Abstract][Full Text] [Related]
5. Quantitative film autoradiography of opiate agonist and antagonist binding in rat brain.
Geary WA; Wooten GF
J Pharmacol Exp Ther; 1983 Apr; 225(1):234-40. PubMed ID: 6300375
[TBL] [Abstract][Full Text] [Related]
6. Indirect involvement of delta opioid receptors in cholecystokinin octapeptide-induced analgesia in mice.
Hong EK; Takemori AE
J Pharmacol Exp Ther; 1989 Nov; 251(2):594-8. PubMed ID: 2553928
[TBL] [Abstract][Full Text] [Related]
7. Modulation of rat brain opioid receptors by cannabinoids.
Vaysse PJ; Gardner EL; Zukin RS
J Pharmacol Exp Ther; 1987 May; 241(2):534-9. PubMed ID: 3033219
[TBL] [Abstract][Full Text] [Related]
8. Decrease in delta and mu opioid receptor binding capacity in rat brain after chronic etorphine treatment.
Tao PL; Law PY; Loh HH
J Pharmacol Exp Ther; 1987 Mar; 240(3):809-16. PubMed ID: 3031275
[TBL] [Abstract][Full Text] [Related]
9. Enhanced striatal opioid receptor-mediated G-protein activation in L-DOPA-treated dyskinetic monkeys.
Chen L; Togasaki DM; Langston JW; Di Monte DA; Quik M
Neuroscience; 2005; 132(2):409-20. PubMed ID: 15802193
[TBL] [Abstract][Full Text] [Related]
10. Role of fluidity of membranes on the guanyl nucleotide-dependent binding of cholecystokinin-8S to rat brain cortical membranes.
Rinken A; Harro J; Engström L; Oreland L
Biochem Pharmacol; 1998 Feb; 55(4):423-31. PubMed ID: 9514076
[TBL] [Abstract][Full Text] [Related]
11. Opiate receptor subtypes in the rat hypothalamus and neurointermediate lobe.
Stojilković SS; Dufau ML; Catt KJ
Endocrinology; 1987 Jul; 121(1):384-94. PubMed ID: 3036471
[TBL] [Abstract][Full Text] [Related]
12. Reconstitution of high-affinity opioid agonist binding in brain membranes.
Remmers AE; Medzihradsky F
Proc Natl Acad Sci U S A; 1991 Mar; 88(6):2171-5. PubMed ID: 1848695
[TBL] [Abstract][Full Text] [Related]
13. [3H]pBC 264, a suitable probe for studying cholecystokinin-B receptors: binding characteristics in rodent brains and comparison with [3H]SNF 8702.
Durieux C; Ruiz-Gayo M; Corringer PJ; Bergeron F; Ducos B; Roques BP
Mol Pharmacol; 1992 Jun; 41(6):1089-95. PubMed ID: 1614411
[TBL] [Abstract][Full Text] [Related]
14. Gastrin13 and the C-terminal octapeptide of cholecystokinin are differently coupled to G-proteins in guinea-pig brain membranes.
Lallement JC; Galleyrand JC; Lima-Leite AC; Fulcrand P; Martinez J
Eur J Pharmacol; 1994 May; 267(3):297-305. PubMed ID: 8088368
[TBL] [Abstract][Full Text] [Related]
15. Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles.
Ioja E; Tourwé D; Kertész I; Tóth G; Borsodi A; Benyhe S
Brain Res Bull; 2007 Sep; 74(1-3):119-29. PubMed ID: 17683797
[TBL] [Abstract][Full Text] [Related]
16. Sodium regulation of agonist binding at opioid receptors. I. Effects of sodium replacement on binding at mu- and delta-type receptors in 7315c and NG108-15 cells and cell membranes.
Puttfarcken P; Werling LL; Brown SR; Cote TE; Cox BM
Mol Pharmacol; 1986 Aug; 30(2):81-9. PubMed ID: 3016503
[TBL] [Abstract][Full Text] [Related]
17. In vivo receptor binding of opioid drugs at the mu site.
Rosenbaum JS; Holford NH; Sadée W
J Pharmacol Exp Ther; 1985 Jun; 233(3):735-40. PubMed ID: 2989495
[TBL] [Abstract][Full Text] [Related]
18. Estrogen and CCK1 receptor modification of mu-opioid receptor binding in the cortex of female rats.
Quesada A; Micevych P
Brain Res; 2006 Feb; 1073-1074():316-20. PubMed ID: 16472782
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of guanosine-5'-o-(3-[35S]thio)triphosphate binding in digitonin-permeabilized C6 rat glioma cells: evidence for an organized association of mu-opioid receptors and G protein.
Alt A; McFadyen IJ; Fan CD; Woods JH; Traynor JR
J Pharmacol Exp Ther; 2001 Jul; 298(1):116-21. PubMed ID: 11408532
[TBL] [Abstract][Full Text] [Related]
20. Regulation of gap junctional coupling in isolated pancreatic acinar cell pairs by cholecystokinin-octapeptide, vasoactive intestinal peptide (VIP) and a VIP-antagonist.
Ngezahayo A; Kolb HA
J Membr Biol; 1994 Apr; 139(2):127-36. PubMed ID: 7520502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
